MedPath

Microneedling with Fluorouracil in Patients with Stable Vitiligo

Phase 3
Recruiting
Conditions
vitiligo.
Vitiligo
Registration Number
IRCT20221105056407N2
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

No new lesions and no progression of existing lesions for at least 2 years

Exclusion Criteria

pregnancy
allergy to 5- Fluorouracil
Patients with infectious patches, vitiligo spots on the mucous membrane, Kubner's phenomenon, tendency to keloid or hypertrophic scars.
Coagulation disorders
Other uncontrolled systemic diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.